Correlation Between Mesa Laboratories and Aptevo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mesa Laboratories and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesa Laboratories and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mesa Laboratories and Aptevo Therapeutics, you can compare the effects of market volatilities on Mesa Laboratories and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesa Laboratories with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesa Laboratories and Aptevo Therapeutics.

Diversification Opportunities for Mesa Laboratories and Aptevo Therapeutics

MesaAptevoDiversified AwayMesaAptevoDiversified Away100%
-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mesa and Aptevo is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Mesa Laboratories and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and Mesa Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesa Laboratories are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of Mesa Laboratories i.e., Mesa Laboratories and Aptevo Therapeutics go up and down completely randomly.

Pair Corralation between Mesa Laboratories and Aptevo Therapeutics

Given the investment horizon of 90 days Mesa Laboratories is expected to generate 0.3 times more return on investment than Aptevo Therapeutics. However, Mesa Laboratories is 3.32 times less risky than Aptevo Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Aptevo Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  13,740  in Mesa Laboratories on November 22, 2024 and sell it today you would earn a total of  760.00  from holding Mesa Laboratories or generate 5.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mesa Laboratories  vs.  Aptevo Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-2002040
JavaScript chart by amCharts 3.21.15MLAB APVO
       Timeline  
Mesa Laboratories 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mesa Laboratories are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Mesa Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb100110120130140150
Aptevo Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aptevo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb468101214

Mesa Laboratories and Aptevo Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-8.74-6.55-4.35-2.16-0.03662.314.697.089.4711.85 0.010.020.030.04
JavaScript chart by amCharts 3.21.15MLAB APVO
       Returns  

Pair Trading with Mesa Laboratories and Aptevo Therapeutics

The main advantage of trading using opposite Mesa Laboratories and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesa Laboratories position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.
The idea behind Mesa Laboratories and Aptevo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules